DiveRadGel Email Formats
Pharmaceutical Manufacturing • 
Japan • 1-10 Employees
Key Contact at DiveRadGel
Takashi Nakai
CEO
Company overview
| Headquarters | Japan |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
About DiveRadGel
Our mission is to create groundbreaking cancer immunotherapies that offer hope for curing refractory cancers, and ultimately reduce the suffering of cancer patients. At the core of our development pipeline is a cancer vaccine utilizing Sonanos™, a hyaluronic acid nanogel with immune cell-targeting capabilities. Furthermore, we are advancing the development of a combination therapy with Sonanos™ cancer vaccine and genetically engineered T-cell therapy, offering potential for remission and prevention of recurrence in refractory cancers.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
DiveRadGel has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
DiveRadGel has never raised funding before.
Australia
United Kingdom
South Africa
United States
Frequently asked questions
4.8
40,000 users
